1
|
Hughes GA, Inacio MC, Rowett D, Lang C, Jorissen RN, Corlis M, Sluggett JK. Setting of initiation and factors associated with antidepressant use on entry to long-term care facilities. Br J Clin Pharmacol 2025. [PMID: 39888093 DOI: 10.1111/bcp.16403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Revised: 12/19/2024] [Accepted: 01/08/2025] [Indexed: 02/01/2025] Open
Abstract
AIMS Antidepressant use increases around long-term care facility (LTCF) entry, and initiation during hospitalizations may contribute to this. This study characterized the care setting (i.e., community-based, hospital or LTCF) where antidepressants were initiated and determined associated resident characteristics. METHODS A cross-sectional study including non-Indigenous individuals aged 65-105 years who entered LTCFs in two Australian states during 2015-2019, and were dispensed an antidepressant within 2 months, was conducted. Care settings (community-based, hospital or LTCF) were determined from linked LTCF records, and hospitalizations ≤30 days before LTCF entry. Pharmaceutical claims before and after LTCF entry were screened to determine antidepressant initiation. Multivariate multinomial logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs) for resident characteristics associated with care settings of antidepressant initiation. RESULTS This study included 34 525 residents from 1046 LTCFs. Overall, 27 160 (78.7%) commenced antidepressants prior to entry, 2552 (7.4%) in hospital and 4813 (13.9%) in LTCFs. Mirtazapine constituted 44.8% (n = 1143) of antidepressants initiated in hospitals and 39.5% (n = 1902) in LTCFs. Residents who were aged ≥90 years were more likely to start an antidepressant in the LTCF compared to community-based settings (aOR = 1.97, 95% CI 1.74-2.23). Residents recently using a psychotropic were more likely to start an antidepressant in community-based settings before LTCF entry, compared to a hospital or LTCF. CONCLUSIONS Individuals receiving antidepressants during transition to LTCFs are often already taking antidepressants prior to entry. Future interventions to optimize antidepressant use in LTCFs should consider setting, recency and indication for antidepressant initiation, and ongoing monitoring for safety.
Collapse
Affiliation(s)
- Georgina A Hughes
- University of South Australia, UniSA Clinical & Health Sciences, Adelaide, South Australia, Australia
- Registry of Senior Australians (ROSA), South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia
| | - Maria C Inacio
- Registry of Senior Australians (ROSA), South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia
- University of South Australia, UniSA Allied Health & Human Performance, Adelaide, South Australia, Australia
| | - Debra Rowett
- University of South Australia, UniSA Clinical & Health Sciences, Adelaide, South Australia, Australia
- Drug and Therapeutics Information Service, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia
| | - Catherine Lang
- Registry of Senior Australians (ROSA), South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia
| | - Robert N Jorissen
- Registry of Senior Australians (ROSA), South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia
- University of South Australia, UniSA Allied Health & Human Performance, Adelaide, South Australia, Australia
| | - Megan Corlis
- Australian Nursing & Midwifery Federation SA Branch, Adelaide, South Australia, Australia
| | - Janet K Sluggett
- Registry of Senior Australians (ROSA), South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia
- University of South Australia, UniSA Allied Health & Human Performance, Adelaide, South Australia, Australia
| |
Collapse
|
2
|
Sluggett JK, Caughey GE, Air T, Lang C, Moldovan M, Martin G, Stafford AC, Carter SR, Jackson S, Wesselingh SL, Inacio MC. Health outcomes following provision of Home Medicines Reviews for older people receiving aged care services at home. Res Social Adm Pharm 2024; 20:1064-1069. [PMID: 39187425 DOI: 10.1016/j.sapharm.2024.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2023] [Revised: 07/25/2024] [Accepted: 08/12/2024] [Indexed: 08/28/2024]
Abstract
BACKGROUND The impact of Home Medicines Reviews (HMRs) on long-term health outcomes among individuals receiving long-term in-home aged care services is unknown. OBJECTIVES To examine associations between HMR provision and hospitalization, long-term care facility (LTCF) entry and mortality among older people receiving long-term in-home aged care services. METHODS This retrospective cohort study included individuals aged 65-105 years from three Australian states who accessed in-home aged care services between 2013 and 2017. Using propensity score matching, HMR recipients (n = 1530) were matched to individuals who did not receive an HMR (n = 1530). Associations between HMR provision and outcomes were estimated using multivariable regression models. RESULTS Over a median of 414 days (interquartile range 217-650) of follow-up, HMR provision was not associated with hospitalizations for unplanned events (subdistribution hazard ratio (sHR) 1.04, 95%CI 0.96-1.14), falls-related hospitalizations (sHR 0.97, 95%CI 0.83-1.13), LTCF entry (sHR 0.97, 95%CI 0.83-1.13), or all-cause mortality (adjusted HR 0.86, 95%CI 0.72-1.01). CONCLUSIONS In a cohort of older people receiving long-term in-home aged care services, no differences in unplanned hospitalizations, falls, LTCF entry or mortality were observed those with HMRs compared to those that did not receive an HMR.
Collapse
Affiliation(s)
- Janet K Sluggett
- University of South Australia, UniSA Allied Health and Human Performance, Adelaide, South Australia, Australia; Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
| | - Gillian E Caughey
- University of South Australia, UniSA Allied Health and Human Performance, Adelaide, South Australia, Australia; Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
| | - Tracy Air
- Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
| | - Catherine Lang
- Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
| | - Max Moldovan
- Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; Biometry Hub, Faculty of Sciences, Engineering and Technology, The University of Adelaide, Waite Campus, Urrbrae, South Australia, Australia
| | - Grant Martin
- Australian Association of Consultant Pharmacy, Fyshwick, Australian Capital Territory, Australia
| | - Andrew C Stafford
- Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia
| | - Stephen R Carter
- School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
| | - Shane Jackson
- School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Tasmania, Australia
| | - Steve L Wesselingh
- Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
| | - Maria C Inacio
- University of South Australia, UniSA Allied Health and Human Performance, Adelaide, South Australia, Australia; Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
| |
Collapse
|
3
|
Angley M, Criddle D, Rigby D, Elliott RA, Phillips K, Penm J, Sluggett JK, Gailer J, Thiele H, Page AT, Pauw C, Gillespie S, Shakib S, Yik J. Hospital‐initiated post‐discharge medication reviews in Australia: expert opinion on the barriers and enablers to implementation. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2022. [DOI: 10.1002/jppr.1832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Manya Angley
- Manya Angley Research and Consulting Adelaide Australia
| | - Deirdre Criddle
- Complex Needs Coordination Team and Sir Charles Gairdner Hospital Pharmacy Department Sir Charles Gairdner Hospital Nedlands Australia
| | | | - Rohan A. Elliott
- Pharmacy Department, Austin Health and Faculty of Pharmacy and Pharmaceutical Sciences, Monash University Melbourne Australia
| | | | - Jonathan Penm
- Faculty of Medicine and Health, School of Pharmacy The University of Sydney Sydney Australia
- Department of Pharmacy Prince of Wales Hospital Randwick Australia
| | - Janet K. Sluggett
- UniSA Allied Health and Human Performance University of South Australia Adelaide Australia
- Registry of Senior Australians South Australian Health and Medical Research Institute Adelaide Australia
- Centre for Medicine Use and Safety Monash University Parkville Australia
| | - Joy Gailer
- Drug and Therapeutics Information Service Southern Adelaide Local Health Network Adelaide Australia
| | - Horst Thiele
- Hospital in the Home Service (HITH) Northern Sydney Local Health District Sydney Australia
| | - Amy T. Page
- Centre for Optimisation of Medicines, School of Allied Health and WA Centre for Health and Ageing University of Western Australia Perth Australia
| | - Carly Pauw
- Hospital in the Home (HITH), Integrated Community Health Western Sydney Local Health District Sydney Australia
| | - Sarah Gillespie
- Australian Association of Consultant Pharmacy Canberra Australia
| | | | - Jerry Yik
- The Society of Hospital Pharmacists of Australia Melbourne Australia
| |
Collapse
|
4
|
McCarthy LM, Farrell B, Howell P, Quast T. Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning. EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY 2022; 7:100168. [PMID: 36045709 PMCID: PMC9420956 DOI: 10.1016/j.rcsop.2022.100168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 06/17/2022] [Accepted: 08/09/2022] [Indexed: 11/26/2022] Open
Abstract
Approaches for optimizing medication use and enhancing medication experiences, including deprescribing, for older people living in long-term care homes are urgently needed. Through a multiphase initiative involving an environmental scan (2018) and two stakeholder forums (2019, 2020), we created a framework for developing and implementing sustainable deprescribing practices in this sector. Representatives from public advocacy, health care professionals, long-term care, pharmacy service providers, and regional health and public policy organizations in Ontario, Canada were consulted. We used behavioural science and implementation planning strategies to develop four target behaviours and 14 supporting actions; five of these actions were prioritized for further work. Throughout the phases, stakeholders committed to participation at various levels including ongoing implementation teams working to develop resources for the prioritized actions. A key element of success was attracting and sustaining engagement of a wide variety of relevant stakeholders from across the health system by leveraging best practices in stakeholder engagement. The approach used is described in detail so that it can be adapted and applied by others to plan large behaviour change initiatives.
Collapse
|
5
|
Haider I, Naunton M, Davey R, Peterson GM, Baqir W, Kosari S. How Do Pharmacists Practice in Aged Care? A Narrative Review of Models from Australia, England, and the United States of America. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph182312773. [PMID: 34886501 PMCID: PMC8657381 DOI: 10.3390/ijerph182312773] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 11/29/2021] [Accepted: 11/30/2021] [Indexed: 01/08/2023]
Abstract
Medication management in residential aged care facilities (RACFs) is complex and often sub-optimal. Pharmacist practice models and services have emerged internationally to address medication-related issues in RACFs. This narrative review aimed to explore pharmacist practice models in aged care in Australia, England and the USA, and identify key activities and characteristics within each model. A search strategy using key terms was performed in peer-reviewed databases, as well as the grey literature. Additionally, experts from the selected countries were consulted to obtain further information about the practice models in their respective countries. Thirty-six documents met the inclusion criteria and were included in the review. Four major pharmacist practice models were identified and formed the focus of the review: (1) the NHS’s Medicine Optimisation in Care Homes (MOCH) program from England; (2) the Australian model utilising visiting accredited pharmacists; (3) the Centers for Medicare and Medicaid (CMS) pharmacy services in long-term care from the USA; and (4) the Medication Therapy Management (MTM) program from the USA. Medication reviews were key activities in all models, but each had distinct characteristics in relation to the comprehensiveness, who is eligible, and how frequently residents receive medication review activity. There was heterogeneity in the types of facility-level activities offered by pharmacists, and further research is needed to determine the effectiveness of these activities in improving quality use of medicines in the aged care setting. This review found that in some models, pharmacists have a limited level of collaboration with other healthcare professionals, emphasising the need to trial innovative models with integrated services and increased collaboration to achieve a holistic patient-centred approach to medication management.
Collapse
Affiliation(s)
- Ibrahim Haider
- Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; (M.N.); (G.M.P.); (S.K.)
- Health Research Institute, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia;
- Correspondence:
| | - Mark Naunton
- Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; (M.N.); (G.M.P.); (S.K.)
| | - Rachel Davey
- Health Research Institute, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia;
| | - Gregory M. Peterson
- Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; (M.N.); (G.M.P.); (S.K.)
- School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7001, Australia
| | - Wasim Baqir
- NHS England and NHS Improvement, London SE1 6LH, UK;
| | - Sam Kosari
- Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia; (M.N.); (G.M.P.); (S.K.)
| |
Collapse
|
6
|
Al Meslamani AZ, Kassem AB, El‐Bassiouny NA, Ibrahim OM. An emergency plan for management of COVID-19 patients in rural areas. Int J Clin Pract 2021; 75:e14563. [PMID: 34165849 PMCID: PMC8420210 DOI: 10.1111/ijcp.14563] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Accepted: 06/21/2021] [Indexed: 11/29/2022] Open
Abstract
AIMS OF THE STUDY To describe the experience of six hospitals in the management of COVID-19 patients in rural areas through an assessment of proportions, types and clinical outcomes of remote clinical interventions. METHODS This was a prospective observational study conducted in six Egyptian hospitals over a period five months. An emergency response was implemented in each hospital in order to connect clinical pharmacists with COVID-19 patients living in rural areas. Pharmacists used phone calls and social media applications, such as WhatsApp® to conduct two types of interventions; (a) Proactive interventions and (b) outcome-based interventions. IBM SPSS V26 was used for data analysis. RESULTS Of the 418 patients included, 351 (83.97%) recovered, 60 (14.35%) were hospitalised and 7 (1.67%) were deceased. Medication orders per patient, high-alert medications per patient and prescribing errors per patient were 5.82, 1.45 and 0.74, respectively. Telepharmacy teams conducted 3318 phone calls, 2116 WhatsApp® chats and 1128 interventions, of which 812 (71.92%) were process-based and 316 (27.98%) were outcome-based. Among these interventions, four significant determinants of improvement in clinical outcomes were found: substitution of a prescribed drug (Adjusted odds ratio [AOR] = 4.03; 95% confidence interval [CI], 2.54-5.87), adding a drug to the prescription (AOR = 3.15; 95% CI, 1.87-4.76), advice the patient to stop smoking (AOR = 3.53; 95% CI, 1.98-5.17) and cessation of drug therapy (AOR = 3.11; 95% CI, 1.25-4.55). The most common medications involved in drug-related interventions were Hydroxychloroquine, Azithromycin and Paracetamol. CONCLUSION Our findings demonstrate significant impact of the remote pharmacist interventions on both medicines use and clinical outcomes of COVID-19 patients in rural areas. Pharmacists in developing countries should be supported to implement remote clinical services to provide patients in rural places with optimal care.
Collapse
Affiliation(s)
| | - Amira B. Kassem
- Clinical Pharmacy and Pharmacy Practice DepartmentFaculty of PharmacyDamanhour UniversityDamanhourEgypt
| | - Noha A. El‐Bassiouny
- Clinical Pharmacy and Pharmacy Practice DepartmentFaculty of PharmacyDamanhour UniversityDamanhourEgypt
| | - Osama Mohamed Ibrahim
- Department of Pharmacy Practice and PharmacotherapeuticsCollege of University of SharjahSharjahUAE
- Department of Clinical PharmacyFaculty of PharmacyCairo UniversityCairoEgypt
| |
Collapse
|
7
|
Svensberg K, Kalleberg BG, Rosvold EO, Mathiesen L, Wøien H, Hove LH, Andersen R, Waaktaar T, Schultz H, Sveaass N, Hellesö R. Interprofessional education on complex patients in nursing homes: a focus group study. BMC MEDICAL EDUCATION 2021; 21:504. [PMID: 34560852 PMCID: PMC8464088 DOI: 10.1186/s12909-021-02867-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Accepted: 07/26/2021] [Indexed: 06/13/2023]
Abstract
BACKGROUND An ageing population leads up to increasing multi-morbidity and polypharmacy. This demands a comprehensive and interprofessional approach in meeting patients' complex needs. This study describes graduate students' experiences of working practice based in interprofessional teams with complex patients' care needs in nursing homes. METHOD Students from advanced geriatric nursing, clinical nutrition, dentistry, medicine and pharmacy at the University of Oslo in Norway were assigned to groups to examine and develop a care plan for a nursing home patient during a course. Focus groups were used, 21 graduate students participating in four groups. Data were collected during spring 2018, were inductively analysed according to a thematic analysis method (Systematic Text Condensation). An analytical framework of co-ordination practices was applied to get an in-depth understanding of the data. RESULTS Three themes were identified: 1) Complex patients as learning opportunities- an eye-opener for future interprofessional collaboration 2) A cobweb of relations, and 3) Structural facilitators for new collective knowledge. Graduate university students experienced interprofessional education (IPE) on complex patients in nursing homes as a comprehensive learning arena. Overall, different co-ordination practices for work organization among the students were identified. CONCLUSIONS IPE in nursing homes facilitated the students' scope from a fragmented approach of the patients towards a relational and collaborative practice that can improve patient care and strengthen understanding of IPE. The study also demonstrated the need for preparatory teamwork training to gain maximum benefit from the experience. Something that can be organized by the education institutions in the form of a stepwise learning module and as an online pre-training course in interprofessional teamwork. Further, focusing on the need for well thought through processes of the activity by the institutions and the timing the practice component in students' curricula. This could ensure that IPE is experienced more efficient by the students.
Collapse
Affiliation(s)
- K. Svensberg
- Section for Pharmaceutics and Social Pharmacy, Department of Pharmacy, University of Oslo, Oslo, Norway
- Department of Pharmacy, Faculty of Pharmacy, University of Uppsala, P.O. Box 580, 751 23 Uppsala, Sweden
| | - B. G. Kalleberg
- Faculty of Medicine, University of Oslo, P.O. 1078, 0316 Blindern, Oslo Norway
| | - E. O. Rosvold
- Faculty of Medicine, University of Oslo, P.O. 1078, 0316 Blindern, Oslo Norway
| | - L. Mathiesen
- Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. 1068, 0316 Blindern, Oslo Norway
| | - H. Wøien
- Department of Nursing Science, Institute of Health and Society, Faculty of Medicine, University of Oslo, P.O. 1130, 0318 Blindern, Oslo Norway
| | - L. H. Hove
- Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, P.O 1109, 0317 Blindern, Oslo Norway
| | - R. Andersen
- Institute of Health and Society, Faculty of Medicine, University of Oslo, P.O. 1130, 0318 Blindern, Oslo Norway
| | - T. Waaktaar
- Department of Psychology, University of Oslo, P.O. 1094, 0317 Blindern, Oslo Norway
| | - H. Schultz
- Department of Pharmacy, University of Oslo, P.O. 1068, 0316 Blindern, Oslo Norway
| | - N. Sveaass
- Department of Psychology, University of Oslo, P.O. 1094, 0317 Blindern, Oslo Norway
| | - R. Hellesö
- Department of Nursing Science, Institute of Health and Society, Faculty of Medicine, University of Oslo, P.O. 1130, 0318 Blindern, Oslo Norway
| |
Collapse
|